| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M804955200 |
| P8608 | Fatcat ID | release_3y3byxucubh6xfnsuet66o3gni |
| P698 | PubMed publication ID | 19047063 |
| P5875 | ResearchGate publication ID | 23559996 |
| P50 | author | Midori Shima | Q111804989 |
| P2093 | author name string | Akira Yoshioka | |
| Yoichi Sakata | |||
| Keiji Nogami | |||
| Katsumi Nishiya | |||
| Masahiro Takeyama | |||
| Kenichi Ogiwara | |||
| Tetsuhiro Soeda | |||
| P2860 | cites work | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 |
| Structure of the C2 domain of human factor VIII at 1.5 A resolution | Q27620583 | ||
| Crystal structure of human factor VIII: implications for the formation of the factor IXa-factor VIIIa complex | Q27650288 | ||
| Identification of the phospholipid binding site in the vitamin K-dependent blood coagulation protein factor IX | Q27732837 | ||
| Structural integrity of the gamma-carboxyglutamic acid domain of human blood coagulation factor IXa Is required for its binding to cofactor VIIIa | Q28116089 | ||
| Molecular cloning of a cDNA encoding human antihaemophilic factor | Q28268498 | ||
| Structure of human factor VIII | Q28630991 | ||
| Antigenicity of putative phospholipid membrane-binding residues in factor VIII. | Q31775088 | ||
| Structure-function relationships in factor IX and factor IXa. | Q35055282 | ||
| Sequence of the murine factor VIII cDNA. | Q36763337 | ||
| Residue 225 determines the Na(+)-induced allosteric regulation of catalytic activity in serine proteases | Q37289290 | ||
| The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX. | Q38362540 | ||
| Na+ site in blood coagulation factor IXa: effect on catalysis and factor VIIIa binding | Q40418012 | ||
| Factor IXa:factor VIIIa interaction. helix 330-338 of factor ixa interacts with residues 558-565 and spatially adjacent regions of the a2 subunit of factor VIIIa | Q43560122 | ||
| 3-Dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography | Q43878410 | ||
| The Gla domain of factor IXa binds to factor VIIIa in the tenase complex | Q44463045 | ||
| Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor Xase | Q44861371 | ||
| Mechanisms of interactions of factor X and factor Xa with the acidic region in the factor VIII A1 domain | Q44912906 | ||
| Factor VIII inhibitors in mild and moderate-severity haemophilia A. | Q45855037 | ||
| Expression of active human factor VIII from recombinant DNA clones | Q45862746 | ||
| Specific detection of human coagulation factor IX in cynomolgus macaques | Q45873385 | ||
| Common inhibitory effects of human anti-C2 domain inhibitor alloantibodies on factor VIII binding to von Willebrand factor | Q45875920 | ||
| Real-time competitive kinetic analysis of interactions between low-molecular-weight ligands in solution and surface-immobilized receptors | Q47370870 | ||
| The A2 subunit of factor VIIIa modulates the active site of factor IXa. | Q47828224 | ||
| Determination of rate and equilibrium binding constants for macromolecular interactions using surface plasmon resonance: use of nonlinear least squares analysis methods. | Q52392958 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3379-3388 | |
| P577 | publication date | 2008-12-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | The factor VIIIa C2 domain (residues 2228-2240) interacts with the factor IXa Gla domain in the factor Xase complex | |
| P478 | volume | 284 |
| Q37441223 | Activation mechanisms of coagulation factor IX. |
| Q30153398 | Changes in the Factor VIII C2 domain upon membrane binding determined by hydrogen-deuterium exchange MS. |
| Q30384710 | Dimeric Organization of Blood Coagulation Factor VIII bound to Lipid Nanotubes. |
| Q57803175 | Emicizumab, a humanized bispecific antibody to coagulation factors IXa and X with a factor VIIIa-cofactor activity |
| Q52666862 | Factor VIIIa-mimetic cofactor activity of a bispecific antibody to factors IX/IXa and X/Xa, emicizumab, depends on its ability to bridge the antigens. |
| Q47950005 | Heme binds to factor VIII and inhibits its interaction with activated factor IX. |
| Q84798069 | Mechanisms of factor VIIa‐catalyzed activation of factor VIII |
| Q36896861 | Membrane-binding properties of the Factor VIII C2 domain |
| Q45878590 | Mild hemophilia A patient with novel Pro1809Leu mutation develops an anti-C2 antibody inhibiting allogeneic but not autologous factor VIII activity. |
| Q41905130 | Modification of interdomain interfaces within the A3C1C2 subunit of factor VIII affects its stability and activity |
| Q42187640 | Next generation FIX muteins with FVIII-independent activity for alternative treatment of hemophilia A. |
| Q36310238 | Structure of the Human Factor VIII C2 Domain in Complex with the 3E6 Inhibitory Antibody |
| Q27680123 | Structure of the factor VIII C2 domain in a ternary complex with 2 inhibitor antibodies reveals classical and nonclassical epitopes |
Search more.